[{"@context":"http:\/\/schema.org\/","@type":"BlogPosting","@id":"https:\/\/wiki.edu.vn\/jp\/wiki3\/archives\/1762#BlogPosting","mainEntityOfPage":"https:\/\/wiki.edu.vn\/jp\/wiki3\/archives\/1762","headline":"\u30a4\u30df\u30ed\u30ad\u30b5\u30f3 – Wikipedia","name":"\u30a4\u30df\u30ed\u30ad\u30b5\u30f3 – Wikipedia","description":"\u30a4\u30df\u30ed\u30ad\u30b5\u30f3(Imiloxan)\u306f\u3001\u79d1\u5b66\u7814\u7a76\u306b\u7528\u3044\u3089\u308c\u308b\u85ac\u54c1\u3067\u3042\u308b\u3002\u03b12B\u30a2\u30c9\u30ec\u30ca\u30ea\u30f3\u53d7\u5bb9\u4f53\u3068\u3057\u3066\u4f5c\u7528\u3057[1]\u3001\u7570\u306a\u308b\u03b12\u30a2\u30c9\u30ec\u30ca\u30ea\u30f3\u53d7\u5bb9\u4f53\u30b5\u30d6\u30bf\u30a4\u30d7\u3092\u533a\u5225\u3059\u308b\u306e\u306b\u7528\u3044\u3089\u308c\u308b[2][3]\u3002 \u30a4\u30df\u30ed\u30ad\u30b5\u30f3\u306e\u5408\u6210[4] \u30a4\u30df\u30ed\u30ad\u30b5\u30f3\u306e\u30a4\u30df\u30c0\u30be\u30fc\u30eb\u90e8\u5206\u306f\u3001\u30a2\u30df\u30ce\u30a2\u30bb\u30c8\u30a2\u30eb\u30c7\u30d2\u30c9\u306e\u30b8\u30a8\u30c1\u30eb\u30a2\u30bb\u30bf\u30fc\u30eb\u90e8\u5206\u3068\u30ab\u30eb\u30dc\u30ad\u30b7\u30df\u30c0\u30fc\u30c8\u3068\u306e\u53cd\u5fdc\u306b\u3088\u308a\u4f5c\u3089\u308c\u3001\u30e8\u30a6\u5316\u30a8\u30c1\u30eb\u3067\u30a4\u30df\u30c0\u30be\u30fc\u30eb\u3092N-\u30a2\u30eb\u30ad\u30eb\u5316\u3059\u308b\u3053\u3068\u3067\u5408\u6210\u3055\u308c\u308b\u3002 ^ \u201cAssessment of imiloxan as a selective alpha 2B-adrenoceptor antagonist\u201d. British Journal of Pharmacology 99 (3): 560-4.","datePublished":"2020-07-31","dateModified":"2020-07-31","author":{"@type":"Person","@id":"https:\/\/wiki.edu.vn\/jp\/wiki3\/archives\/author\/lordneo#Person","name":"lordneo","url":"https:\/\/wiki.edu.vn\/jp\/wiki3\/archives\/author\/lordneo","image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/c9645c498c9701c88b89b8537773dd7c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c9645c498c9701c88b89b8537773dd7c?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Enzyklop\u00e4die","logo":{"@type":"ImageObject","@id":"https:\/\/wiki.edu.vn\/wiki4\/wp-content\/uploads\/2023\/08\/download.jpg","url":"https:\/\/wiki.edu.vn\/wiki4\/wp-content\/uploads\/2023\/08\/download.jpg","width":600,"height":60}},"image":{"@type":"ImageObject","@id":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/thumb\/5\/5e\/Imiloxan_synthesis.svg\/500px-Imiloxan_synthesis.svg.png","url":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/thumb\/5\/5e\/Imiloxan_synthesis.svg\/500px-Imiloxan_synthesis.svg.png","height":"172","width":"500"},"url":"https:\/\/wiki.edu.vn\/jp\/wiki3\/archives\/1762","about":["Wiki"],"wordCount":1372,"articleBody":"\u30a4\u30df\u30ed\u30ad\u30b5\u30f3(Imiloxan)\u306f\u3001\u79d1\u5b66\u7814\u7a76\u306b\u7528\u3044\u3089\u308c\u308b\u85ac\u54c1\u3067\u3042\u308b\u3002\u03b12B\u30a2\u30c9\u30ec\u30ca\u30ea\u30f3\u53d7\u5bb9\u4f53\u3068\u3057\u3066\u4f5c\u7528\u3057[1]\u3001\u7570\u306a\u308b\u03b12\u30a2\u30c9\u30ec\u30ca\u30ea\u30f3\u53d7\u5bb9\u4f53\u30b5\u30d6\u30bf\u30a4\u30d7\u3092\u533a\u5225\u3059\u308b\u306e\u306b\u7528\u3044\u3089\u308c\u308b[2][3]\u3002  \u30a4\u30df\u30ed\u30ad\u30b5\u30f3\u306e\u5408\u6210[4]  \u30a4\u30df\u30ed\u30ad\u30b5\u30f3\u306e\u30a4\u30df\u30c0\u30be\u30fc\u30eb\u90e8\u5206\u306f\u3001\u30a2\u30df\u30ce\u30a2\u30bb\u30c8\u30a2\u30eb\u30c7\u30d2\u30c9\u306e\u30b8\u30a8\u30c1\u30eb\u30a2\u30bb\u30bf\u30fc\u30eb\u90e8\u5206\u3068\u30ab\u30eb\u30dc\u30ad\u30b7\u30df\u30c0\u30fc\u30c8\u3068\u306e\u53cd\u5fdc\u306b\u3088\u308a\u4f5c\u3089\u308c\u3001\u30e8\u30a6\u5316\u30a8\u30c1\u30eb\u3067\u30a4\u30df\u30c0\u30be\u30fc\u30eb\u3092N-\u30a2\u30eb\u30ad\u30eb\u5316\u3059\u308b\u3053\u3068\u3067\u5408\u6210\u3055\u308c\u308b\u3002^ \u201cAssessment of imiloxan as a selective alpha 2B-adrenoceptor antagonist\u201d. British Journal of Pharmacology 99 (3):  560-4. (March 1990). doi:10.1111\/j.1476-5381.1990.tb12968.x. PMC\u00a01917331..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:\"\"\"\"\"\"\"'\"\"'\"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url(\"\/\/upload.wikimedia.org\/wikipedia\/commons\/6\/65\/Lock-green.svg\")right 0.1em center\/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url(\"\/\/upload.wikimedia.org\/wikipedia\/commons\/d\/d6\/Lock-gray-alt-2.svg\")right 0.1em center\/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url(\"\/\/upload.wikimedia.org\/wikipedia\/commons\/a\/aa\/Lock-red-alt-2.svg\")right 0.1em center\/9px no-repeat}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url(\"\/\/upload.wikimedia.org\/wikipedia\/commons\/4\/4c\/Wikisource-logo.svg\")right 0.1em center\/12px no-repeat}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}PMID\u00a01970500. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1917331\/.\u00a0^ \u201cPharmacological evidence that alpha2A- and alpha2C-adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats\u201d. European Journal of Pharmacology 554 (2-3):  205-11. (January 2007). doi:10.1016\/j.ejphar.2006.09.068. PMID\u00a017109851.\u00a0^ \u201cProbable involvement of alpha(2C)-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine\u201d. European Journal of Pharmacology 608 (1-3):  23-7. (April 2009). doi:10.1016\/j.ejphar.2009.02.019. PMID\u00a019236861.\u00a0^ \u201cStructure-activity relationships for 2-substituted imidazoles as alpha 2-adrenoceptor antagonists\u201d. Journal of Medicinal Chemistry 25 (6):  666-70. (June 1982). doi:10.1021\/jm00348a012. PMID\u00a06124635.\u00a0\u5916\u90e8\u30ea\u30f3\u30af[\u7de8\u96c6] \u30a6\u30a3\u30ad\u30e1\u30c7\u30a3\u30a2\u30fb\u30b3\u30e2\u30f3\u30ba\u306b\u306f\u3001\u30a4\u30df\u30ed\u30ad\u30b5\u30f3\u306b\u95a2\u3059\u308b\u30ab\u30c6\u30b4\u30ea\u304c\u3042\u308a\u307e\u3059\u3002"},{"@context":"http:\/\/schema.org\/","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https:\/\/wiki.edu.vn\/jp\/wiki3\/#breadcrumbitem","name":"Enzyklop\u00e4die"}},{"@type":"ListItem","position":2,"item":{"@id":"https:\/\/wiki.edu.vn\/jp\/wiki3\/archives\/1762#breadcrumbitem","name":"\u30a4\u30df\u30ed\u30ad\u30b5\u30f3 – Wikipedia"}}]}]